Meet Anna Dimitrova, our Chief Financial Officer at Scailyte AG. In our latest episode of “Inside Scailyte,” Anna shares her journey, insights, and vision for our company.
Continue readingScaiPod: Revolutionizing Immuno-Oncology With Multi-Omics and AI at Scale
ScaiPod’s mission is clear: develop next-generation clinical biomarkers for precise immuno-oncology treatments, shedding light on ICI resistance and irAEs, and paving the way for innovative therapeutics.
Continue readingMeet Scailyte at Immuno-Oncology 360° in New York, USA
Our very own Diana Stoycheva and Peter Nestorov will be representing Scailyte at the conference at booth 16. Diana will be delivering a presentation that you won’t want to miss on the topic of “AI-Powered Identification of Neurotoxicity Predictive Cell Signature in CAR-T Cell Therapy for DLBCL” on February 28 at 4:20PM!
Continue readingScaiDigest Volume 7: Unveiling Insights into Autoimmune Diseases
We’re thrilled to share the latest installment of our ScaiDigest series, authored by our very own Diana Stoycheva! In this volume, Diana delves into the fascinating world of autoimmune diseases, shedding light on groundbreaking research and advancements in single-cell technologies that are revolutionizing our understanding of these complex conditions.
Continue readingInside Scailyte – Episode 4: Meet Peter Evans
In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. Pete’s expertise in IT and his commitment to ensuring that our technology empowers groundbreaking discoveries is pivotal to our mission.
Continue reading